I last wrote on AbbVie stock (NYSE:ABBV) back in July 2024, a bit more than two months ago. In that article, I explained my thought process for exiting the position from our income account. The key ...
The company continues to grow aggressively but the techncials are not responding. Margins continue to increase and EPS guidance gets tightened to the upside. Given that Donaldson is a proven dividend ...
Realty Income (O) has once again caught investors’ attention, but not because of any headline-grabbing event or dramatic announcement. Instead, the spotlight has turned to the stock as it continues to ...
Yield is defined as cash dividends paid over the past four quarters, divided by share price. For many investors, it is tied with the price/earnings ratio at the top of investors’ go-to list. Yield is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results